logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Channing J. Paller

VA Boston Healthcare System
H指数:41
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent effects of PLA2G7 on prostate cancer biochemical recurrence in European American and African American men

PLA2G7对欧洲裔和非洲裔美国男性前列腺癌生化复发的不同影响

JNCI: Journal of the National Cancer Institute
IF0
2026-03-130
PRE
Channing J Paller, MD; Shuanzeng Wei, MD, PhD; Megan Schumacher, MS; Daniel Rabizadeh, MS; Yu-Ching Hsu, PhD; Changxue Lu, PhD; Yidong Chen, PhD; Yuezhou Jing, MS; Bruce J Trock, PhD; Mayuko Kanayama, MD, PhD; Stefan Ambs, PhD, MPH; Diana M Stafforini, PhD; William B Isaacs, PhD; George J Netto, MD; Tamara L Lotan, MD; Angelo M De Marzo, MD, PhD; Elizabeth A Platz, ScD, MPH; Jun Luo, PhD; null
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer

PARP抑制剂和药理学抗坏血酸在去势抵抗性前列腺癌中表现出协同作用

Molecular Oncology
IF4.5
2026-01-140
OAAI
Nicolas Gordon; Peter T. Gallagher; Orly I. Richter; Neermala Poudel Neupane; Amy C. Mandigo; Jennifer J. McCann; Emanuela Dylgjeri; Irina Vasilevskaya; Christopher McNair; Channing J. Paller; Wm. Kevin Kelly; Karen E. Knudsen; Matthew J. Schiewer; Ayesha A. Shafi
[68Ga]Ga-PSMA-11 PET Tumor Volume Predicts Overall Survival of Patients with Metastatic Prostate Cancer Undergoing Taxane-Based Chemotherapy

[(68)Ga]Ga-PSMA-11 PET肿瘤体积可预测接受紫杉烷类化疗的转移性前列腺癌患者的总生存期

JOURNAL OF NUCLEAR MEDICINE
IF9.1
2025-11-011
PRE
Beintner-Skawran, Stephan; Gafita, Andrei; Lorenzini, Theo; Tauber, Robert; Hoberueck, Sebastian; Mattana, Francesco; Di Giorgio, Andrea; Miederer, Matthias; Paller, Channing J.; Djaileb, Loic; Solnes, Lilja B.; Farolfi, Andrea; Ceci, Francesco; Eiber, Matthias; Voter, Andrew F.
Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant

蛇皮葡萄提取物在生物化学复发性前列腺癌中的应用：一项针对携带SOD2 Ala/Ala变异患者的随机、安慰剂对照、生物标志物富集试验

PROSTATE
IF2.5
2025-05-050
PRE
Mandl, A.; Zahurak, M. L.; Metri, N. A.; Shore, N. D.; Mao, S.; McKay, R. R.; Taplin, M. E.; Szmulewitz, R. Z.; Maughan, B. L.; Reichert, Z. R.; Kessler, E. R.; Heath, E. I.; Dreicer, R.; Stein, C. A.; Milne, G. L.; Sfanos, K. S.; Ernst, S. E.; Mummert, L. A.; Cruz-Lebron, A.; Michel, S. L. J.; Kane, M. A.; Hursey, M.; Worth, M. A.; Wagner, W. D.; Eshleman, J. R.; Debeljak, M.; Xu, L.; Cao, H.; Dowling, D.; Marshall, C. H.; Markowski, M. C.; Denmeade, S. R.; Eisenberger, M. A.; Antonarakis, E. S.; Carducci, M. A.; Paller, C. J.
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes

从前列腺癌患者肿瘤DNA测序中推断出的克隆性造血：与肿瘤体细胞改变及预后的相关性

ONCOLOGIST
IF4.2
2025-04-220
OA
Iranmanesh, Yasaman; Omar, Noha; Rasouli, Arya; Baras, Alex; Pasca, Sergiu; Gondek, Lukasz P.; Tsai, Hua-Ling; Denmeade, Samuel R.; Carducci, Michael A.; Paller, Channing J.; Markowski, Mark C.; Luo, Jun; Eisenberger, Mario A.; Antonarakis, Emmanuel S.
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor

CRM1调节雄激素受体稳定性并影响前列腺癌中的DNA修复途径，独立于雄激素受体

FASEB JOURNAL
IF4.2
2025-01-280
OA
Kumar, Rajendra; Mendonca, Janet; Shetty, Abhishek; Yang, Yuhan; Owoyemi, Olutosin; Wilson, Lillian; Boyapati, Kavya; Topiwala, Deven; Thomas, Naiju; Nguyen, Huong; Luo, Jun; Paller, Channing J.; Denmeade, Samuel R.; Carducci, Michael A.; Kachhap, Sushant K.
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone- sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

3个月和7个月的前列腺特异性抗原水平可作为转移性激素敏感性前列腺癌总生存期的预后指标: SWOG S1216的结果，这是一项雄激素剥夺加Orteronel或比卡鲁胺的3期随机试验

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-10-012
OA
Parikh, Mamta; Tangen, Catherine; Hussain, Maha H. A.; Gupta, Shilpa; Callis, Sam; Jo, Yeonjung; Harzstark, Andrea; Paller, Channing J.; George, Saby; Zibelman, Matthew R.; Cheng, Heather H.; Maughan, Benjamin L.; Zhang, Jingsong; Pachynski, Russell K.; Bryce, Alan H.; Lin, Daniel W.; Quinn, David I.; Lerner, Seth P.; Thompson, Ian M.; Dorff, Tanya B.; Lara, Primo N.; Agarwal, Neeraj
Abiraterone, Olaparib, or Abiraterone plus Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)
CLINICAL CANCER RESEARCH
IF10.2
2024-08-084
PRE
Hussain, Maha; Kocherginsky, Masha; Agarwal, Neeraj; Adra, Nabil; Zhang, Jingsong; Paller, Channing J.; Picus, Joel; Reichert, Zachery R.; Szmulewitz, Russell Z.; Tagawa, Scott T.; Kuzel, Timothy M.; Bazzi, Latifa A.; Daignault-Newton, Stephanie; Whang, Young E.; Dreicer, Robert; Stephenson, Ryan D.; Rettig, Matthew B.; Shevrin, Daniel; Gerke, Travis; Chinnaiyan, Arul M.; Antonarakis, Emmanuel S.
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial
NATURE COMMUNICATIONS
IF15.7
2024-01-026
OAAI
Markowski, Mark C.; Taplin, Mary-Ellen; Aggarwal, Rahul; Sena, Laura A.; Wang, Hao; Qi, Hanfei; Lalji, Aliya; Sinibaldi, Victoria; Carducci, Michael A.; Paller, Channing J.; Marshall, Catherine H.; Eisenberger, Mario A.; Sanin, David E.; Yegnasubramanian, Srinivasan; Gomes-Alexandre, Carolina; Ozbek, Busra; Jones, Tracy; De Marzo, Angelo M.; Denmeade, Samuel R.; Antonarakis, Emmanuel S.

研究方向

暂未获取到该数据
M
Michael A. Carducci
H 指数:104论文数:1,049被引数:5.4万
E
Emmanuel S. Antonarakis
H 指数:82论文数:1,051被引数:3.5万
M
Mario A. Eisenberger
H 指数:91论文数:750被引数:4.5万
S
Samuel R. Denmeade
H 指数:64论文数:560被引数:1.7万
M
Mark C. Markowski
H 指数:30论文数:329被引数:2,703
P
Phuoc T. Tran
H 指数:67论文数:732被引数:1.5万
S
Stephen Greco
H 指数:19论文数:68被引数:2,343
K
Kenneth J. Pienta
H 指数:142论文数:1,412被引数:8.3万
C
Curtiland Deville
H 指数:39论文数:324被引数:6,375
T
Theodore L. DeWeese
H 指数:64论文数:738被引数:1.7万